Skip to content

A Study on Pain After Breast Reconstruction

Persistent Postmastectomy Pain: Defining the Burden of Disease and the Role of Surgical Reinnervation in Patients With Breast Reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06627582
Enrollment
274
Registered
2024-10-04
Start date
2024-10-01
Completion date
2027-10-01
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Breast Reconstruction After Mastectomy, Mastectomy, Mastectomy and Breast Reconstruction, Mastectomy Patient, Postmastectomy Pain

Keywords

Postmastectomy Pain, breast reconstruction after mastectomy, breast reconstruction, mastectomy and breast reconstruction, mastectomy, mastectomy patient, 24-271, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to find out how common persistent postmastectomy pain (PPMP) is among people who have had a mastectomy and breast reconstruction surgery for their breast cancer. The study will also look at how effective regenerative peripheral nerve interface (RPNI) surgery is for reducing pain from neuropathic PPMP after breast reconstruction.

Interventions

BEHAVIORALPROMIS Scale v2.0 - Pain Intensity 3a

PROMIS Scale v2.0 - Pain Intensity 3a is a 3-question short form in which patients rate their worst, average, and current level of pain during the past 7 days.

BEHAVIORALPROMIS 29+2

PROMIS 29+2 (PROMIS-Preference, PROPr) is a compilation of item banks to assess pain intensity

BEHAVIORALPROMIS Scale v2.0 - Nociceptive Pain Quality 5a

5-question short form that identifies patients who have experienced nociceptive pain during the past 7 days

BEHAVIORALPROMIS Scale v2.0 - Neuropathic Pain Quality 5a

5-question short form that identifies patients who have experienced neuropathic pain during the past 7 days

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female * Age ≥18 years * History of mastectomy for breast cancer or genetic predisposition to breast cancer * History of breast reconstruction with implants and/or autologous tissue * At least 6 months of follow-up after reconstruction * Patient treated at MSK

Exclusion criteria

* Exchange or revision surgery within 6 months * Active medical reason for pain (e.g., infectious, neoplastic, wound related) * Greater than 15 years post-reconstruction

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with Persistent Postmastectomy Painup to 6 monthsThe primary objective is to estimate the prevalence of Persistent Postmastectomy Pain/PPMP in breast cancer survivors treated with mastectomy and reconstruction.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDanielle Rochlin, MD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026